Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$710K Buy
9,675
+3,151
+48% +$248K 0.24% 34
2019
Q4
$566K Buy
6,524
+151
+2% +$12.4K 0.12% 45
2019
Q3
$512K Sell
6,373
-1,174
-16% -$94.1K 0.11% 49
2019
Q2
$599K Buy
7,547
+1,552
+26% +$119K 0.13% 51
2019
Q1
$476K Sell
5,995
-1,504
-20% -$112K 0.11% 48
2018
Q4
$547K Buy
7,499
+945
+14% +$66.7K 0.12% 50
2018
Q3
$444K Buy
6,554
+175
+3% +$11.1K 0.08% 60
2018
Q2
$369K Buy
6,379
+4,005
+169% +$226K 0.08% 72
2018
Q1
$123K Buy
+2,374
New +$128K 0.03% 208

Other funds holding MRK

JOYN Advisors's MRK Position: Q1 2020 in Review

JOYN Advisors increased its Merck (MRK) stake by 48% in Q1 2020, buying an estimated $248K and bringing the position to 9,675 shares worth $710K. The position accounts for 0.24% of the portfolio, ranked #34.

JOYN Advisors first reported a position in MRK in Q1 2018 and has held it in 9 quarters since. 2,477 funds tracked by Wall St. Rank hold MRK as of Q1 2020.

  • JOYN Advisors held 9,675 shares of Merck worth $710K as of Q1 2020.
  • JOYN Advisors bought 3,151 Merck shares in Q1 2020, an estimated $248K.
  • Merck made up 0.24% of JOYN Advisors's portfolio in Q1 2020, its #34 holding.
  • JOYN Advisors first reported a position in Merck in Q1 2018 and has held it in 9 quarters since.
  • 2,477 funds tracked by Wall St. Rank held Merck as of Q1 2020.

Based on JOYN Advisors's 13F filing for Q1 2020, filed 30 Apr 2020.